PROGRAM FEATURES

Virtual reality headsets provided to attendees for viewing this presentation only

Create your own personalized poster

Interactive, case-based learning environment

PROGRAM DESCRIPTION

While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.

LEARNING OBJECTIVES

Review recent pathophysiological findings in AD that have informed the selection of new therapeutic targets

Describe best practices for severity assessment and diagnosis of moderate-to-severe AD in pediatric patients, accounting for biomarkers, phenotype/genotype, comorbidities, and disease burden

Explain the mechanisms of action and clinical profiles of new and emerging targeted systemic agents for the long-term treatment of AD in pediatric patients

Discuss how different biomarkers, comorbidities and adherence barriers play a role in long-term treatment decision making for pediatric patients with AD

TARGET AUDIENCE

This activity is intended for US-based dermatologists and other health care professionals who diagnose, treat, and/or manage patients with AD.

DISCLAIMER

Med Learning Group makes every effort to develop activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For questions, please contact Med Learning Group at info@medlearninggroup.com.
Privacy and confidentiality policy statement information is available at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com